James A Landro

Title: James A. Landro: Innovator in Biotechnology

Introduction

James A. Landro is a notable inventor based in Cheshire, CT (US), recognized for his contributions to biotechnology. With a focus on developing innovative solutions, he holds 2 patents that address significant health challenges.

Latest Patents

One of his latest patents is titled "Anti-ApoC3 antibodies and methods of use thereof." This invention provides antibodies that specifically bind to ApoC3, particularly human ApoC3, and antagonize its function. The patent also includes pharmaceutical compositions comprising these antibodies, nucleic acids encoding them, expression vectors, and host cells for their production. Additionally, it outlines methods for treating subjects using these antibodies. Another significant patent is the "Method for assaying enzyme activity," which relates to assessing enzyme activity through a phase partition system. This invention also encompasses methods for screening and identifying compounds that may be beneficial for treating diabetes, obesity, cardiovascular disease, cancer, and other related disorders.

Career Highlights

Throughout his career, James has worked with prominent companies in the biotechnology sector, including Staten Biotechnology B.V. and Bayer Pharmaceuticals Corporation. His experience in these organizations has contributed to his expertise in developing innovative biotechnological solutions.

Collaborations

James has collaborated with notable professionals in the field, including Paul DaSilva-Jardine and Hans De Haard. These partnerships have further enhanced his research and development efforts.

Conclusion

James A. Landro's work in biotechnology exemplifies the impact of innovation on health and medicine. His patents reflect a commitment to addressing critical health issues through scientific advancement.